|
regulation of ion transport
|
GO:0043269 |
215 |
0.247
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.168
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.168
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.166
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.132
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.111
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.101
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.098
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.096
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.094
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.093
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.086
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.080
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.079
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.078
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.076
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.073
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.071
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.070
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.070
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.069
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.069
|
|
|
digestion
|
GO:0007586 |
40 |
0.069
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.068
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.068
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.068
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.068
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.067
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.066
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.066
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.066
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.064
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.064
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.064
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.064
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.061
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.061
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.061
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.060
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.059
|
|
|
memory
|
GO:0007613 |
58 |
0.059
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.058
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.057
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.056
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.056
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.055
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.052
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.052
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.051
|
|
|
action potential
|
GO:0001508 |
78 |
0.051
|
|
|
cation transport
|
GO:0006812 |
399 |
0.050
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.050
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.049
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.049
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.049
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.048
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.046
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.045
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.045
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.044
|
|
|
positive regulation of ion transmembrane transporter activity
|
GO:0032414 |
15 |
0.044
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.043
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.043
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.043
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.043
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.042
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.042
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.040
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.040
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.039
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.039
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.039
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.039
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.038
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.038
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.038
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.038
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.038
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.038
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.037
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.037
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.037
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.037
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.037
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.036
|
|
|
response to drug
|
GO:0042493 |
75 |
0.036
|
|
|
atrioventricular node cell development
|
GO:0060928 |
2 |
0.036
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.036
|
|
|
appendage development
|
GO:0048736 |
166 |
0.036
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.035
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.035
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.035
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.034
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.034
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.034
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.034
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.033
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.033
|
|
|
regulation of digestive system process
|
GO:0044058 |
13 |
0.033
|
|
|
positive regulation of sodium ion transport
|
GO:0010765 |
13 |
0.032
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.032
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.032
|
|
|
response to amphetamine
|
GO:0001975 |
16 |
0.032
|
|
|
fucosylation
|
GO:0036065 |
9 |
0.032
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.032
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.032
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.031
|
|
|
placenta development
|
GO:0001890 |
140 |
0.031
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.031
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.031
|
|
|
habituation
|
GO:0046959 |
3 |
0.031
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.031
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.031
|
|
|
organ growth
|
GO:0035265 |
117 |
0.031
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.031
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.030
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.030
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.030
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.030
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.030
|
|
|
bronchiole morphogenesis
|
GO:0060436 |
1 |
0.030
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.029
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.029
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.029
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.029
|
|
|
myelination
|
GO:0042552 |
74 |
0.029
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.029
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.029
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.029
|
|
|
heart process
|
GO:0003015 |
94 |
0.029
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.029
|
|
|
reflex
|
GO:0060004 |
22 |
0.028
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.028
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.028
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.028
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.028
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
20 |
0.028
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.028
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.027
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.027
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.027
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.027
|
|
|
lung development
|
GO:0030324 |
164 |
0.027
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.027
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.027
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.027
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.027
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.027
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.027
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.027
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.027
|
|
|
negative regulation of keratinocyte differentiation
|
GO:0045617 |
4 |
0.027
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.026
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.026
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.026
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.026
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.026
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.026
|
|
|
positive regulation of high voltage gated calcium channel activity
|
GO:1901843 |
1 |
0.025
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.025
|
|
|
negative regulation of macrophage activation
|
GO:0043031 |
2 |
0.025
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.025
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.025
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.025
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.025
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.025
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.025
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.025
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.024
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.024
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.024
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.024
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.024
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.024
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.024
|
|
|
regulation of membrane depolarization
|
GO:0003254 |
11 |
0.024
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.024
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.024
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.024
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.024
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.024
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.024
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.024
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.024
|
|
|
positive regulation of white fat cell proliferation
|
GO:0070352 |
1 |
0.023
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.023
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.023
|
|
|
type b pancreatic cell fate commitment
|
GO:0003327 |
1 |
0.023
|
|
|
rhodopsin mediated signaling pathway
|
GO:0016056 |
4 |
0.023
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.023
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.023
|
|
|
regulation of membrane depolarization during cardiac muscle cell action potential
|
GO:1900825 |
1 |
0.023
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.023
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.023
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.023
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.023
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.022
|
|
|
atrioventricular node cell fate commitment
|
GO:0060929 |
1 |
0.022
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.022
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.022
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.022
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.022
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.022
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.022
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.022
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.022
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.022
|
|
|
cognition
|
GO:0050890 |
149 |
0.022
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.022
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.022
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.021
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.021
|
|
|
positive regulation of fat cell proliferation
|
GO:0070346 |
1 |
0.021
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.021
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.021
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.021
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.021
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.021
|
|
|
regulation of timing of cell differentiation
|
GO:0048505 |
11 |
0.021
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.021
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.021
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.021
|
|
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.021
|
|
|
mammary gland bud formation
|
GO:0060615 |
2 |
0.020
|
|
|
negative regulation of interleukin 5 secretion
|
GO:2000663 |
1 |
0.020
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.020
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.020
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.020
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.020
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.020
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.020
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.020
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.020
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.020
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.020
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.020
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.019
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.019
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.019
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.019
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.019
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.019
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.019
|
|
|
regulation of water loss via skin
|
GO:0033561 |
16 |
0.019
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.019
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.018
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.018
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.018
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.018
|
|
|
liver development
|
GO:0001889 |
66 |
0.018
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.018
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.018
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.018
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.018
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.018
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.018
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.018
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.018
|
|
|
primary alcohol metabolic process
|
GO:0034308 |
11 |
0.018
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.018
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.017
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.017
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.017
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.017
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.017
|
|
|
establishment or maintenance of neuroblast polarity
|
GO:0045196 |
1 |
0.017
|
|
|
regulation of macrophage activation
|
GO:0043030 |
17 |
0.017
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.017
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.017
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.017
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.017
|
|
|
male genitalia morphogenesis
|
GO:0048808 |
4 |
0.017
|
|
|
response to amine
|
GO:0014075 |
16 |
0.017
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.017
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.017
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.017
|
|
|
serotonin transport
|
GO:0006837 |
11 |
0.017
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.016
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.016
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.016
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.016
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.016
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.016
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.016
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.016
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.016
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.016
|
|
|
establishment of neuroblast polarity
|
GO:0045200 |
1 |
0.016
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.016
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.016
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.016
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.016
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.016
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.016
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.016
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.016
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.015
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.015
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.015
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.015
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.015
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.015
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.015
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.015
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.015
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.015
|
|
|
sodium ion homeostasis
|
GO:0055078 |
7 |
0.015
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.015
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.015
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.015
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.015
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.015
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.015
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.015
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.015
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.015
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.015
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.015
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.015
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.015
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.014
|
|
|
ear development
|
GO:0043583 |
200 |
0.014
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.014
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.014
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.014
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.014
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.014
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.014
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.014
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.014
|
|
|
submandibular salivary gland formation
|
GO:0060661 |
1 |
0.014
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.014
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.014
|
|
|
dopamine transport
|
GO:0015872 |
15 |
0.014
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.014
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.014
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.014
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.014
|
|
|
activation of phospholipase c activity
|
GO:0007202 |
2 |
0.014
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.014
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.014
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.014
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.014
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.014
|
|
|
cell migration to the midline involved in heart development
|
GO:0003318 |
1 |
0.014
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.014
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.014
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.014
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.014
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.014
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.014
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.014
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.013
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.013
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.013
|
|
|
cell cell signaling involved in lung development
|
GO:0060495 |
1 |
0.013
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.013
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.013
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.013
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.013
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.013
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.013
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.013
|
|
|
regulation of calcium ion transmembrane transport
|
GO:1903169 |
20 |
0.013
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.013
|
|
|
regulation of high voltage gated calcium channel activity
|
GO:1901841 |
2 |
0.013
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.013
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.013
|
|
|
regulation of white fat cell proliferation
|
GO:0070350 |
2 |
0.013
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.013
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.013
|
|
|
ossification
|
GO:0001503 |
216 |
0.013
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.013
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.013
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.013
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.013
|
|
|
defecation
|
GO:0030421 |
1 |
0.013
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.013
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.013
|
|
|
semicircular canal fusion
|
GO:0060879 |
1 |
0.013
|
|
|
behavioral response to cocaine
|
GO:0048148 |
10 |
0.012
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.012
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.012
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.012
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.012
|
|
|
purkinje myocyte development
|
GO:0003165 |
1 |
0.012
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.012
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.012
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.012
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
38 |
0.012
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.012
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.012
|
|
|
regulation of protein depolymerization
|
GO:1901879 |
26 |
0.012
|
|
|
sensitization
|
GO:0046960 |
2 |
0.012
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.012
|
|
|
lung proximal distal axis specification
|
GO:0061115 |
1 |
0.012
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.012
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.012
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.012
|
|
|
wound healing
|
GO:0042060 |
157 |
0.012
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.012
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.012
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.012
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.012
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.012
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.012
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.012
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.012
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.012
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.012
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.012
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.012
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.011
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.011
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.011
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.011
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.011
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.011
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.011
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.011
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.011
|
|
|
harderian gland development
|
GO:0070384 |
2 |
0.011
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.011
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.011
|
|
|
regulation of organic acid transport
|
GO:0032890 |
16 |
0.011
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.011
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.011
|
|
|
organ induction
|
GO:0001759 |
21 |
0.011
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.011
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.011
|
|
|
regulation of keratinocyte proliferation
|
GO:0010837 |
15 |
0.011
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.011
|
|
|
negative regulation of t cell cytokine production
|
GO:0002725 |
1 |
0.011
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.011
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.011
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.011
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.011
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.011
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.011
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.011
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.011
|
|
|
gland development
|
GO:0048732 |
330 |
0.011
|
|
|
dopamine receptor signaling pathway
|
GO:0007212 |
16 |
0.011
|
|
|
mesenchymal cell differentiation involved in lung development
|
GO:0060915 |
2 |
0.011
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.011
|
|
|
glial cell fate specification
|
GO:0021780 |
5 |
0.011
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.011
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.011
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.011
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.011
|
|
|
myoblast proliferation
|
GO:0051450 |
11 |
0.011
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.011
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.011
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.011
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.011
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.011
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.011
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.011
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.010
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.010
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.010
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.010
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.010
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.010
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.010
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.010
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.010
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.010
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.010
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.010
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.010
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
2 |
0.010
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.010
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.010
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.010
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.010
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.010
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.010
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.010
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.010
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.010
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.010
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.010
|
|
|
detection of light stimulus
|
GO:0009583 |
25 |
0.010
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.010
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.010
|
|